Basic Information
| LncRNA/CircRNA Name | DUXAP8 |
| Synonyms | NA |
| Region | GRCh38_22:15784959-15829984 |
| Ensemble | ENSG00000206195 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | esophageal cancer |
| ICD-0-3 | C15 |
| Methods | qPCR, etc. |
| Sample | cell lines (KYSE510, KYSE30) |
| Expression Pattern | up-regulated |
| Function Description | knockdown of DUXAP8 could impair esophageal cancer cells proliferation and invasion in vitro. the two lncRNAs associated protein-coding genes involve with many known biological processes, such as cell cycle and cell-cell adherens junction. |
| Pubmed ID | 29926523 |
| Year | 2018 |
| Title | A genome-wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer. |
External Links
| Links for DUXAP8 | GenBank HGNC NONCODE |
| Links for esophageal cancer | OMIM COSMIC |